Susceptibility to acute rheumatic fever based on differential expression of genes involved in cytotoxicity, chemotaxis, and apoptosis

Infection and Immunity

Volumn 82, Issue 2, 2014, Pages 753-761

  Bryant, Penelope A ^a,b,h   Smyth, Gordon K ^c,g   Gooding, Travis ^b   Oshlack, Alicia ^b   Harrington, Zinta ^d   Currie, Bart ^d,e   Carapetis, Jonathan R ^f   Robins Browne, Roy ^b,g   Curtis, Nigel ^a,b,h  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e ROYAL DARWIN HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g Department of Microbiology and Immunology ^*  (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RNA;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DISEASE PREDISPOSITION; DNA MICROARRAY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A;

ADULT; APOPTOSIS; CHEMOTAXIS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84893020280     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01152-13     Document Type: Article

References (32)

1. Carapetis JR, Currie BJ, Mathews JD. 2000. Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol. Infect. 124:239-244. http://dx.doi.org/10.1017 /S0950268800003514.
2. Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L. 2005. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J. Autoimmun. 24:101-109. http://dx.doi.org /10.1016/j.jaut.2005.01.007.
3. Davies A, Lazarov E. 1960. Heredity, infection and chemoprophylaxis in rheumatic carditis: an epidemiologic study of a communal settlement. J. Hyg. 58:263-269. http://dx.doi.org/10.1017/S0022172400038377.
4. Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. 2009. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 119:742-753. http://dx.doi.org/10.1161/CIRCULATIONAHA.108 .792135.
5. Bryant PA, Venter D, Robins-Browne R, Curtis N. 2004. Chips with everything: DNA microarrays in infectious diseases. Lancet Infect. Dis. 4:100-111. http://dx.doi.org/10.1016/S1473-3099(04)00930-2.
6. Harrington Z, Visvanathan K, Skinner NA, Curtis N, Currie BJ, Carapetis JR. 2006. B-cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings. Med. J. Aust. 184:507-510.
7. Smyth GK. 2005. Limma: linear models for microarray data, p 397-420. In Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (ed), Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
8. Smyth GK, Speed TP. 2003. Normalization of cDNA microarray data. Methods 31:265-273. http://dx.doi.org/10.1016/S1046-2023(03)00155-5.
9. Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A, Smyth GK. 2006. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7:261. http://dx.doi.org/10.1186 /1471-2105-7-261.
10. Smyth GK, Michaud J, Scott HS. 2005. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:2067-2075. http://dx.doi.org/10.1093/bioinformatics /bti270.
11. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article 3. http://dx.doi.org/10.2202/1544-6115.1027.
12. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289-300.
13. Beissbarth T, Speed TP. 2004. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20:1464-1465. http://dx.doi.org/10.1093/bioinformatics/bth088.
14. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. 2005. A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037. http://dx.doi.org/10.1038/nature03985.
15. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS. 2006. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl. Acad. Sci. U. S. A. 103:17402-17407. http://dx.doi.org/10.1073/pnas.0608396103.
16. Ideker T, Ozier O, Schwikowski B, Siegel AF. 2002. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18(Suppl 1):S233-S240. http://dx.doi.org/10.1093/bioinformatics /18.suppl_1.S233.
17. Li Y, Heuser JS, Kosanke SD, Hemric M, Cunningham MW. 2005. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. Am. J. Pathol. 167:5-15. http://dx.doi.org/10.1016/S0002-9440(10)62948-3.
18. Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U. 2001. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 103: 18-21. http://dx.doi.org/10.1161/01.CIR.103.1.18.
19. Cunningham MW. 2004. T cell mimicry in inflammatory heart disease. Mol. Immunol. 40:1121-1127. http://dx.doi.org/10.1016/j.molimm.2003 .11.023.
20. Guilherme L, Cury P, Demarchi LM, Coelho V, Abel L, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto E, Pomerantzeff PM, Tanaka AC, Kalil J. 2004. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am. J. Pathol. 165:1583-1591. http://dx.doi.org/10.1016/S0002-9440(10)63415-3.
21. Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. 1989. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin. Immunol. Immunopathol. 52:225-237. http://dx.doi.org/10.1016 /0090-1229(89)90174-8.
22. Bhatnagar A, Grover A, Ganguly NK. 1999. Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients. Clin. Exp. Immunol. 116:100-106.
23. Miller LC, Gray ED, Mansour M, Abdin ZH, Kamel R, Zaher S, Regelmann WE. 1989. Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. J. Rheumatol. 16:1436-1442.
24. Morris K, Mohan C, Wahi PL, Anand IS, Ganguly NK. 1993. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin. Exp. Immunol. 91:429-436.
25. Bhatia R, Narula J, Reddy KS, Koicha M, Malaviya AN, Pothineni RB, Tandon R, Bhatia ML. 1989. Lymphocyte subsets in acute rheumatic fever and rheumatic heart disease. Clin. Cardiol. 12:34-38. http://dx.doi .org/10.1002/clc.4960120106.
26. Morris K, Mohan C, Wahi PL, Anand IS, Ganguly NK. 1993. Increase in activated T cells and reduction in suppressor/cytotoxic T cells in acute rheumatic fever and active rheumatic heart disease: a longitudinal study. J. Infect. Dis. 167:979-983. http://dx.doi.org/10.1093/infdis/167.4.979.
27. Bryant PA, Smyth GK, Robins-Browne R, Curtis N. 2009. Detection of gene expression in an individual cell type within a cell mixture using microarray analysis. PLoS One 4:e4427. http://dx.doi.org/10.1371/journal .pone.0004427.
28. Cunningham MW. 2003. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front. Biosci. 8:s533-543. http://dx.doi.org/10.2741/1067.
29. Guilherme L, Oshiro SE, Fae KC, Cunha-Neto E, Renesto G, Goldberg AC, Tanaka AC, Pomerantzeff PM, Kiss MH, Silva C, Guzman F, Patarroyo ME, Southwood S, Sette A, Kalil J. 2001. T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heartinfiltrating T lymphocytes in rheumatic heart disease patients. Infect. Immun. 69:5345-5351. http://dx.doi.org/10.1128/IAI.69.9.5345-5351.2001.
30. Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW. 2001. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J. Infect. Dis. 183:507-511. http://dx.doi .org/10.1086/318076.
31. Navratil JS, Liu CC, Ahearn JM. 2006. Apoptosis and autoimmunity. Immunol. Res. 36:3-12. http://dx.doi.org/10.1385/IR:36:1:3.
32. Puck JM, Sneller MC. 1997. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Semin. Immunol. 9:77-84. http://dx.doi.org/10.1006/smim.1996.0056.